Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41536-020-00105-z http://scihub22266oqcxt.onion/10.1038/s41536-020-00105-z 33580031!7589470!33580031     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       NPJ+Regen+Med 2020 ; 5 (1): 17 Nephropedia Template TP {{tp|p=33580031|t=2020. Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure |pdf=|usr=}}{{33580031}} gab.com Text Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure JO: NPJ Regen Med http://www.kidney.de/pget.php?&tw=1&pmid=33580031 #FOAvip The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the end of 2019 in Hubei province China, is now the cause of a global pandemic present in over 150 countries. COVID-19 is a respiratory illness with most subjects presenting with fever, cough and shortness of breath. In a subset of patients, COVID-19 progresses to hypoxic respiratory failure and acute respiratory distress syndrome (ARDS), both of which are mediated by widespread inflammation and a dysregulated immune response. Mesenchymal stem cells (MSCs), multipotent stromal cells that mediate immunomodulation and regeneration, could be of potential benefit to a subset of COVID-19 subjects with acute respiratory failure. In this review, we discuss key features of the current COVID-19 outbreak, and the rationale for MSC-based therapy in this setting, as well as the limitations associated with this therapeutic approach. Twit Text FOAVip Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure ????NPJ Regen Med http://www.kidney.de/pget.php?&tw=1&pmid=33580031 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33580031 #FOAvip English Wikipedia <ref>{{Cite pmid|33580031}}</ref> Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure #MMPMID33580031 Durand N; Mallea J; Zubair AC NPJ Regen Med 2020[Oct]; 5 (1): 17 PMID33580031show ga The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the end of 2019 in Hubei province China, is now the cause of a global pandemic present in over 150 countries. COVID-19 is a respiratory illness with most subjects presenting with fever, cough and shortness of breath. In a subset of patients, COVID-19 progresses to hypoxic respiratory failure and acute respiratory distress syndrome (ARDS), both of which are mediated by widespread inflammation and a dysregulated immune response. Mesenchymal stem cells (MSCs), multipotent stromal cells that mediate immunomodulation and regeneration, could be of potential benefit to a subset of COVID-19 subjects with acute respiratory failure. In this review, we discuss key features of the current COVID-19 outbreak, and the rationale for MSC-based therapy in this setting, as well as the limitations associated with this therapeutic approach. äInsights into the use of mesenchymal stem cells in COVID-19 mediated a(epmc).pdf DeepDyve Pubget Overpricing